Answer
Teduglutide (Revestive) treats short bowel syndrome in patients aged 4 months corrected gestational age and above who are stable following a period of intestinal adaptation after surgery.
Sources for this answer
- Revestive 5 mg powder and solvent for solution for injectionTakeda UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 17Document updated
Sources checked